Targeting TYK2 for Immune-Mediated Inflammatory Diseases

Tyrosine kinase 2 (TYK2) is an important member of the Janus kinase (JAK) protein family. While other JAKs regulate broader biological processes, like blood cell development and metabolic activity, TYK2 is involved in immune-specific signaling. Through ongoing research into TYK2, we are developing a better understanding of distinct approaches targeting key drivers of immune-mediated inflammatory diseases, like psoriasis and psoriatic arthritis. Intended for healthcare professionals for scientific/medical education only. Voiced by Salome Juethner, US Medical Head of Dermatology & Rheumatology at Takeda. Watch more TYK2 Talks videos:    • TYK2 Talks: The TYK2 Pathway   Learn about our focus areas: https://www.takeda.com/science/areas-... Follow us on LinkedIn:   / takeda-pharmaceuticals